Since 2006, the Phospholipid Research Center has been funding research into phospholipid excipients in drugs

Dermal
All categoriesBasic ResearchDepotDermalDrug DeliveryOralParenteral
All aggregates
nano plasma membrane vesicle-lipid nanoparticle (nPMV-LNP) hybridsBolalipidsSynthetic single-chain bolalipids (SSCBs)CochleatesColloidsEmulsionsExosomesExtrudatesImplantsLamellaeLipid dispersionsLipodisksLiposomesMicrobubblesMicroparticlesMixed Micelles / MicellesMonolayerNanofibersSelf-assembling (Lipid)NanoparticlesSelf-emulsifying SystemsSolid Dispersions / DispersionsTablets
ongoing
Any statusfinishedongoing
DermalA hydrogen peroxide-sensing liposomal hydrogel for molecular diagnostics in diabetic wounds

Prof. Dr. Simon Matoori – Université de Montréal, Canada and Prof. Dr. Aristidis Veves – Beth Israel Deaconess Medical Center, a Harvard Medical School Teaching Hospital, USA

Since 2024
Dermal, Drug DeliveryFormulation of lipid nanoparticles (LNP) encapsulating micro-RNA for topical treatment of high-grade squamous intraepithelial lesions (HSIL) lesion

Dr. Mohamadreza Amin – Erasmus University Medical Center Rotterdam, The Netherlands

Since 2024
DermalPhospholipid-based emulsifiers for sunscreen development: impact of UVA and effect on skin properties in vitro, ex vivo, and in vivo

Mag. Dr. Victoria Klang – University of Vienna, Austria

Since 2022